Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective

Area of Science:

• Neuroscience
• Pharmacology
• Geriatrics

Background:

• Vascular dementia (VaD) is the second leading cause of dementia in older adults, characterized by cognitive decline due to cerebrovascular issues.
• The exact causes of VaD remain unclear, hindering effective treatment development.
• Current treatments offer only symptomatic relief and do not halt disease progression.

Purpose of the Study:

• To review the current state of pharmacological treatments for VaD.
• To examine treatments in relation to key molecular mechanisms of VaD pathogenesis.
• To identify potential future therapeutic strategies for VaD.

Main Methods:

• Literature review of current research on VaD pharmacological treatments.
• Analysis of studies focusing on molecular mechanisms: oxidative stress, cholinergic system, neuroinflammation, apoptosis, and synaptic plasticity.
• Synthesis of findings to evaluate treatment efficacy and future directions.

Main Results:

• No approved standard treatments currently exist for VaD.
• Existing drugs provide only symptomatic relief.
• Understanding molecular pathways offers targets for novel therapeutic approaches.

Conclusions:

• Pharmacological treatments for VaD are limited and primarily symptomatic.
• Targeting multiple molecular mechanisms, such as oxidative stress and neuroinflammation, is a promising avenue.
• Combined therapeutic strategies hold potential for future VaD management.